To say that pharmacy retailer Walgreens Boots Alliance (NASDAQ: WBA) has been struggling would be a massive understatement.

The pharmacy “allowed millions of opioid pills and other controlled substances to flow illegally out of Walgreens stores,” ...

Shares of Walgreens Boots Alliance (NASDAQ: WBA) fell sharply last year as a combination of declining vaccine demand, ...

The biggest losers in the S&P 500 all faced disappointing sales and earnings. But large declines and extreme volatility can ...

Walgreens improving pharmacy business and comments from the company’s CEO are convincing Wall Street that the drugstore won't ...

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Walgree ...

This is an ongoing story and will be updated after Walgreens' earnings call | Drugstore chain Walgreens reported a loss of ...

Turns out putting everything behind locked glass and ad-covered screens does not create a welcoming shopping environment.

Shares of Walgreens (WBA) are trading higher on an earnings beat. They may be breaking the resistance around the $11 level.

Terrence Antonio James / Chicago Tribune / Tribune News Service / Getty Images Walgreens is set to report earnings Friday morning. The pharmacy chain was the worst-performing stock in the S&P 500 ...

Walgreens Boots Alliance has seen a significant decline in stock price, with my position down 75%, leading me to reaffirm my "Hold" rating. WBA's dividend yield is 10.5%, but sustainability is ...

Walgreens stock is cheap, although it faces a number ... Expansion outside of Walgreens' core geographical footprint turned out to be unprofitable, and its plans to use the service as a funnel ...